Strumento inattivo

Altre lingue Oxis International Euronext Paris

Azioni

US6918295014

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

GT BIOPHARMA ANNOUNCES FDA CLEARANCE OF INVESTIGATIONAL NEW DRUG APPLICATION FOR GTB-3650, AN NK CELL ENGAGER FOR TREATMENT OF CD33+ LEUKEMIA	28/06
GT Biopharma Says FDA Clears Investigational New Drug Application for Cancer Drug GTB-3650	27/06
GT Biopharma Shares Rise on FDA Clearance for Cancer-Drug Study	27/06
GT Biopharma Announces FDA Clearance of Investigational New Drug (IND) Application for GTB-3650, an NK Cell Engager for Treatment of CD33+ Leukemia	27/06
GT Biopharma, Inc. Announces FDA Clearance of Investigational New Drug Application for GTB-3650, an NK Cell Engager for Treatment of CD33+ Leukemia	27/06
GT Biopharma, Inc. Announces CFO Changes	07/06
Top Midday Decliners	21/05
GT Biopharma Prices $3.2 Million Registered Direct Offering of Shares, Concurrent Private Placement of Warrants	21/05
GT Biopharma, Inc. Announces $3.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules	21/05
Top Premarket Gainers	20/05
GT Biopharma Reports First Quarter 2024 Financial Results and Provides Corporate Update	15/05
GT Biopharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	15/05
Caterpillar deja París, el cacao está menos caliente	30/04
Le bric-à-brac de Zonebourse : Caterpillar quitte Paris, le cacao est moins chaud	30/04
GT Biopharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	26/03
GT Biopharma Reports Fourth Quarter and Full-Year 2023 Financial Results	26/03
GT Biopharma to Conduct 1-for-30 Reverse Stock Split; Shares Fall	01/02
GT Biopharma, Inc. Announces 1-for-30 Reverse Stock Split	01/02
LEADING PROXY ADVISORY FIRMS, ISS AND GLASS LEWIS, RECOMMEND GT BIOPHARMA STOCKHOLDERS VOTE 'FOR' ALL PROPOSED ITEMS AT THE UPCOMING SPECIAL MEETING OF STOCKHOLDERS	07/12
Leading Proxy Advisory Firms, ISS and Glass Lewis, Recommend GT Biopharma Stockholders Vote “FOR” All Proposed Items at the Upcoming Special Meeting of Stockholders	06/12

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Oxis International Euronext Paris

Azioni

US6918295014

Altre lingue

Filtri